MARKET

URGN

URGN

Urogen Pharma
NASDAQ
34.49
-0.66
-1.88%
After Hours: 34.49 0 0.00% 19:30 10/23 EDT
OPEN
34.44
PREV CLOSE
35.15
HIGH
35.02
LOW
33.80
VOLUME
738.10K
TURNOVER
--
52 WEEK HIGH
50.81
52 WEEK LOW
16.37
MARKET CAP
1.69B
P/E (TTM)
-17.3841
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Humana (HUM)
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), Genmab (GMAB) and Neogen (NEOG)
TipRanks · 6d ago
UroGen Pharma Price Target Maintained With a $75.00/Share by HC Wainwright & Co.
Dow Jones · 6d ago
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $75 Price Target
Benzinga · 6d ago
UroGen gets FDA review for new bladder cancer therapy
Seeking Alpha · 6d ago
UroGen Pharma announces FDA acceptance of UGN-103 NDA
TipRanks · 6d ago
Weekly Report: what happened at URGN last week (1012-1016)?
Weekly Report · 6d ago
UroGen Pharma management to meet with Oppenheimer
TipRanks · 10/14 19:50
More
About URGN
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Webull offers Urogen Pharma Ltd stock information, including NASDAQ: URGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, URGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading URGN stock methods without spending real money on the virtual paper trading platform.